Dr. Kozyreva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
736 Cambrige Street
Boston, MA 02135Phone+1 617-789-2903Fax+1 617-789-2064
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- Steward Carney HospitalResidency, Internal Medicine, 2004 - 2007
- St Petersburg Medical State AcademyClass of 1993
Certifications & Licensure
- FL State Medical License 2023 - Present
- MA State Medical License 2006 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
- Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer Start of enrollment: 2018 Oct 18
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- ASO Author Reflections: Pseudopapillary Tumor of the Pancreas: Getting the Dosing of Surgery Right.Oscar Salirrosas, Eduardo A Vega, Elena Panettieri, Hamed Harandi, Olga Kozyreva
Annals of Surgical Oncology. 2024-07-01 - The impact of the COVID-19 pandemic on patients with pancreatic cancer.Oscar Salirrosas, Eduardo A Vega, Elena Panettieri, Omid Salehi, Olga Kozyreva
Journal of Gastrointestinal Surgery. 2024-06-01 - ASO Visual Abstract: Solid Pseudopapillary Tumor of the Pancreas-Is Enucleation Safe?Oscar Salirrosas, Eduardo A Vega, Elena Panettieri, Hamed Harandi, Olga Kozyreva
Annals of Surgical Oncology. 2024-06-01
Press Mentions
- SURGE: Supporting UnderRepresented Minorities in Genomics-Based Cancer Trial Enrollment (Intervention)May 16th, 2022
- Immunotherapy Is Lifesaver for Firefighter with Rare Bile Duct CancerJuly 30th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: